Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program
| Image |  |
|---|---|
| Description | scientific article published on 20 December 2019 |
| Author/s | |
| Publication date | December 20, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |